All stock lists
Revelation Biosciences, Inc. (NASDAQ:REVB)
US · Delayed Price · Currency is USD
3.75-0.04 (-1.16%)
Insider Score
––Not scored
REVB Insider Score
Insiders here have filed 7 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
REVB Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 7.20 K | 5.85 K | 6.76 K | 7.22 K | 7.22 K |
| Gross Profit | 0.00 | -7.20 K | -5.85 K | -6.76 K | -7.22 K | -7.22 K |
| SG&A Expense | 1.74 M | 1.71 M | 1.61 M | 1.02 M | 1.14 M | 1.24 M |
| R&D Expense | 1.92 M | 1.38 M | 964.19 K | 922.86 K | 1.32 M | 858.83 K |
| Operating Expenses | 3.66 M | 3.09 M | 2.57 M | 1.94 M | 2.46 M | 2.09 M |
| Operating Income | -3.66 M | -3.09 M | -2.57 M | -1.94 M | -2.46 M | -2.09 M |
| Pretax Income | -3.32 M | -3.01 M | -2.51 M | -1.91 M | -2.44 M | -2.05 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -3.32 M | -3.01 M | -2.51 M | -1.91 M | -2.44 M | -2.05 M |
| EPS (Basic) | -6.09 | -18.97 | -11.55 | -12.39 | -49.07 | -14.77 |
| EPS (Diluted) | -6.09 | -18.97 | -11.55 | -12.39 | -49.07 | -14.77 |
| Shares Outstanding | 547.05 K | 458.25 K | 88.69 K | 377.82 K | 114.67 K | 138.76 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.